Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Epigenetic-modification associated hnRNPA3 acts as a prognostic biomarker and promotes malignant progression of HCC

Fig. 3

Expression and methylation of hnRNPA3 gene in HCC. A DNA methylation of hnRNPA3 in pan-cancer. B The DNA methylation level of cg11064170 between tumors and normal tissues in HCC. C The DNA methylation level of cg11064170 is correlated with the expression level of hnRNPA3. D The DNA methylation level of cg11064170 varies across different stages. E Survival curves of cg11064170 on DFI in HCC. F Survival curves of cg11064170 on OS in HCC. G Survival curves of cg01594915 on OS in HCC. H Survival curves of cg01750051 on DFI in HCC. I, J K, L Correlation between hnRNPA3 and DNMT3L, TET1, TET2, and TET3 in HCC. M, N, O, P Overall survival curves of hnRNPA3 combined with DNMT3L, TET1, TET2, or TET3 in HCC

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us